EV/EBITDA
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary:
NeuBase Therapeutics EV/EBITDA is not available.NBSE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| 6 m6 months | - |
| 1 y1 year | - |
| 5 y5 years | - |
NBSE EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | 0.46 | 0.25 | ||
| 3 y | 3 years | 0.46 | -2.17 | ||
| 5 y | 5 years | 0.46 | -15.45 | ||
| alltime | all time | 80.38 | -72.58 |
NeuBase Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2023 | 0.35(+94.4%) |
| 2022 | 0.18(-110.0%) |
| 2021 | -1.80(-77.5%) |
| 2020 | -8.01(+102.3%) |
| 2019 | -3.96(+708.2%) |
| 2018 | -0.49(-89.9%) |
| 2017 | -4.84(+229.3%) |
| 2016 | -1.47(-85.7%) |
| Date | Value |
|---|---|
| 2015 | -10.28(-47.3%) |
| 2014 | -19.50(-31.8%) |
| 2013 | -28.60(+35.2%) |
| 2012 | -21.15(+246.7%) |
| 2011 | -6.10(-116.2%) |
| 2010 | 37.65(-310.9%) |
| 2009 | -17.85(-57.8%) |
| 2008 | -42.30(+348.1%) |
| 2007 | -9.44 |
FAQ
- What is the all time high EV/EBITDA for NeuBase Therapeutics?
What is the all time high EV/EBITDA for NeuBase Therapeutics?
NeuBase Therapeutics all-time high EV/EBITDA is 80.38